Brief: ROVI Q1 Revenue EUR 151.2 Million

Laboratorios Farmaceuticos Rovi

08/05/2024 06:36

May 08 (Reuters) - ROVI Q1 EBIT EUR 19.3 million.
* Q1 EBITDA EUR 25.9 million
* Q1 free cash flow EUR 6.6 million
* Q1 net income EUR 15 million